The functional groups and heterocyclic classes known to be compatible with a directed C−H activation with [Ru3(CO)12] has been expanded through development of a new substrate screening strategy. Following C−H activation, a library of products is MS-labeled and rapidly evaluated by positive ion electrospray ionization mass spectrometry (see scheme) to directly identify successful products and their yields.
No takes yet. Share an insight, caveat, or question.
Szewczyk et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: